CA1321964C - Method for culturing pearls - Google Patents
Method for culturing pearlsInfo
- Publication number
- CA1321964C CA1321964C CA000578599A CA578599A CA1321964C CA 1321964 C CA1321964 C CA 1321964C CA 000578599 A CA000578599 A CA 000578599A CA 578599 A CA578599 A CA 578599A CA 1321964 C CA1321964 C CA 1321964C
- Authority
- CA
- Canada
- Prior art keywords
- source
- mollusca
- tissue
- nucleus
- nacre
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims description 21
- 239000011049 pearl Substances 0.000 title abstract description 41
- 238000012258 culturing Methods 0.000 title description 7
- 241000237852 Mollusca Species 0.000 claims abstract description 34
- 150000001413 amino acids Chemical class 0.000 claims abstract description 34
- 150000003839 salts Chemical class 0.000 claims abstract description 19
- 150000003431 steroids Chemical class 0.000 claims abstract description 7
- 239000011248 coating agent Substances 0.000 claims abstract description 6
- 238000000576 coating method Methods 0.000 claims abstract description 6
- 239000002609 medium Substances 0.000 claims description 42
- 239000001963 growth medium Substances 0.000 claims description 23
- 235000015097 nutrients Nutrition 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 12
- 230000002710 gonadal effect Effects 0.000 claims description 11
- 150000001720 carbohydrates Chemical class 0.000 claims description 9
- 230000012010 growth Effects 0.000 claims description 9
- 210000002966 serum Anatomy 0.000 claims description 9
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 8
- 239000008103 glucose Substances 0.000 claims description 8
- 241000490567 Pinctada Species 0.000 claims description 6
- 229940041514 candida albicans extract Drugs 0.000 claims description 6
- 238000000338 in vitro Methods 0.000 claims description 6
- 239000012138 yeast extract Substances 0.000 claims description 6
- 210000004369 blood Anatomy 0.000 claims description 5
- 239000008280 blood Substances 0.000 claims description 5
- 230000001605 fetal effect Effects 0.000 claims description 5
- 229930182830 galactose Natural products 0.000 claims description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 4
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 3
- 241000217381 Anodonta Species 0.000 claims description 2
- 241000382825 Cristaria plicata Species 0.000 claims description 2
- 241000545767 Elliptio complanata Species 0.000 claims description 2
- 241000237880 Haliotis cracherodii Species 0.000 claims description 2
- 241000143510 Haliotis discus hannai Species 0.000 claims description 2
- 241000237878 Haliotis fulgens Species 0.000 claims description 2
- 241001522824 Haliotis gigantea Species 0.000 claims description 2
- 241000385245 Ligumia nasuta Species 0.000 claims description 2
- 241001490476 Pinctada maxima Species 0.000 claims description 2
- 241001463804 Pteria macroptera Species 0.000 claims description 2
- 241001655269 Strophitus undulatus Species 0.000 claims description 2
- 241001600163 Tridacna gigas Species 0.000 claims description 2
- 239000012266 salt solution Substances 0.000 claims description 2
- 241000548230 Crassostrea angulata Species 0.000 claims 1
- 244000184734 Pyrus japonica Species 0.000 claims 1
- 241000545760 Unio Species 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 10
- 239000000758 substrate Substances 0.000 abstract description 6
- 239000000654 additive Substances 0.000 abstract description 3
- 238000011534 incubation Methods 0.000 abstract description 2
- 230000010261 cell growth Effects 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 description 59
- 229940024606 amino acid Drugs 0.000 description 27
- 235000001014 amino acid Nutrition 0.000 description 27
- 235000002639 sodium chloride Nutrition 0.000 description 18
- 239000000284 extract Substances 0.000 description 11
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 10
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 7
- 239000005556 hormone Substances 0.000 description 7
- 229940088597 hormone Drugs 0.000 description 7
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 7
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 7
- 229910001868 water Inorganic materials 0.000 description 7
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 6
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 6
- 239000003242 anti bacterial agent Substances 0.000 description 6
- 230000001857 anti-mycotic effect Effects 0.000 description 6
- 229940088710 antibiotic agent Drugs 0.000 description 6
- 239000002543 antimycotic Substances 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 241000237858 Gastropoda Species 0.000 description 5
- 239000004471 Glycine Substances 0.000 description 5
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 5
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 5
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 5
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 5
- 229960003767 alanine Drugs 0.000 description 5
- 239000003098 androgen Substances 0.000 description 5
- 229960005261 aspartic acid Drugs 0.000 description 5
- 239000010984 cultured pearl Substances 0.000 description 5
- 229960003136 leucine Drugs 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 229960001153 serine Drugs 0.000 description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 4
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 4
- 241000237502 Ostreidae Species 0.000 description 4
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 235000004279 alanine Nutrition 0.000 description 4
- 235000003704 aspartic acid Nutrition 0.000 description 4
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 229960002885 histidine Drugs 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229960004452 methionine Drugs 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 235000020636 oyster Nutrition 0.000 description 4
- 229960005190 phenylalanine Drugs 0.000 description 4
- 235000004400 serine Nutrition 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- KZDCMKVLEYCGQX-UDPGNSCCSA-N 2-(diethylamino)ethyl 4-aminobenzoate;(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;hydrate Chemical compound O.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 KZDCMKVLEYCGQX-UDPGNSCCSA-N 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 3
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
- 108010009736 Protein Hydrolysates Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- 235000009697 arginine Nutrition 0.000 description 3
- 229960003121 arginine Drugs 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- 239000012894 fetal calf serum Substances 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 210000002149 gonad Anatomy 0.000 description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 229930182817 methionine Natural products 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 235000001968 nicotinic acid Nutrition 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 239000011664 nicotinic acid Substances 0.000 description 3
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000003531 protein hydrolysate Substances 0.000 description 3
- 239000013535 sea water Substances 0.000 description 3
- 229960005322 streptomycin Drugs 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 101000856746 Bos taurus Cytochrome c oxidase subunit 7A1, mitochondrial Proteins 0.000 description 2
- 241000237890 Haliotis Species 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- 102000004407 Lactalbumin Human genes 0.000 description 2
- 108090000942 Lactalbumin Proteins 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 108091006629 SLC13A2 Proteins 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 239000003636 conditioned culture medium Substances 0.000 description 2
- 229960003067 cystine Drugs 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000013505 freshwater Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- 239000000413 hydrolysate Substances 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 229960002429 proline Drugs 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 229960002898 threonine Drugs 0.000 description 2
- 230000008467 tissue growth Effects 0.000 description 2
- 229960004441 tyrosine Drugs 0.000 description 2
- 229960004295 valine Drugs 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 229910021532 Calcite Inorganic materials 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 235000019743 Choline chloride Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 241000237876 Haliotis corrugata Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000936964 Isognomon Species 0.000 description 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- 235000019766 L-Lysine Nutrition 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 239000004158 L-cystine Substances 0.000 description 1
- 235000019393 L-cystine Nutrition 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 229930182844 L-isoleucine Natural products 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- 235000019454 L-leucine Nutrition 0.000 description 1
- 229930195722 L-methionine Natural products 0.000 description 1
- 229930182821 L-proline Natural products 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 239000007832 Na2SO4 Substances 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- 230000010800 Physiochemical Activity Effects 0.000 description 1
- 241000490568 Pinctada fucata Species 0.000 description 1
- 241001212699 Pinctada martensii Species 0.000 description 1
- 241001463913 Pinna Species 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 241000879903 Pteria Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 238000003917 TEM image Methods 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940030486 androgens Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- FCPVYOBCFFNJFS-LQDWTQKMSA-M benzylpenicillin sodium Chemical compound [Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 FCPVYOBCFFNJFS-LQDWTQKMSA-M 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 1
- 229960003178 choline chloride Drugs 0.000 description 1
- 239000000512 collagen gel Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000635 electron micrograph Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- -1 i.e. Substances 0.000 description 1
- 238000012606 in vitro cell culture Methods 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002667 nucleating agent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000001139 pH measurement Methods 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 238000012876 topography Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical class [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 238000003911 water pollution Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K61/00—Culture of aquatic animals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0601—Invertebrate cells or tissues, e.g. insect cells; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/60—Buffer, e.g. pH regulation, osmotic pressure
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/74—Undefined extracts from fungi, e.g. yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/10—Mineral substrates
- C12N2533/18—Calcium salts, e.g. apatite, Mineral components from bones, teeth, shells
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Environmental Sciences (AREA)
- Marine Sciences & Fisheries (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Farming Of Fish And Shellfish (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
ABSTRACT OF THE DISCLOSURE
Nacre coating of a biocompatible nucleating substrate is achieved by contacting such substrate with mantle tissue explant from a mollusca species under cellular growth promoting conditions. Salt containing media are employed with variations as to the other additives, which may include a source of a steroid material, a source of amino acids, a source of metabolizable energy, or other components. After incubation for sufficient time, nacre coated substrates are formed. By appropriate choice of the nucleus, pearls can be produced.
Nacre coating of a biocompatible nucleating substrate is achieved by contacting such substrate with mantle tissue explant from a mollusca species under cellular growth promoting conditions. Salt containing media are employed with variations as to the other additives, which may include a source of a steroid material, a source of amino acids, a source of metabolizable energy, or other components. After incubation for sufficient time, nacre coated substrates are formed. By appropriate choice of the nucleus, pearls can be produced.
Description
METHOD FOR CULTURING PEARLS
The subject invention concerns coating of nucleating agents with nacre in vitro using mantle tissue 5 from mollusca.
This invention relates to a methods and compositions of matter utilized therein, for culturing pearls, and in particular to a method of producing pearls by using an in vitro cell culture system to maintain biological and physiochemical activities of the mantle tissues found in pearl forming mollusks and gastropods.
A pearl is a gem most commonly formed by bivalve mollusks, particularly by several marine species known as pearl oysters. Pearls are formed as a protection against the irritation caused by foreign objects, generally parasites, grains of sand, or bits of gravel, which lodge inside the shell. A fold of soft tissue envelops the foreign particle and deposits layer after layer of nacre on it, similar to the mother-of-pearl lining the shell. Any shelled mollusk or gastropod is theoretically capable of producing a pearl, but most pearls exhibiting gem quality are produced by a specific genus of pinctada, haliotis, and certain freshwater bivalves.
Techniques for culturing pearls by using live pearl oysters were developed in Japan during the turn of the century. And today, these methods are still employed in which various saltwater and freshwater bivalves are maintained alive during the pearl forming stages.
30 Cultured pearls are generally produced by manuallyimplanting a nucleus with small pieces of mantle tissue in an oyster for approximately two to three years.
Over the years changes in the ecological environment, such as an increase in water pollution and 35 over harvesting of the pearl producing mollusks, have limited the potential productivity of the pearl . ~
.~
.
. ., . ~ .. :
': ' :: ' -: ' ' . ,, . : . ': ,, :
.
13219~
industries. Furthermore, existing methods of culturing pearls have inherent limitations: 1) Large areas of land and sea must be designated and utilized; 2) Pearl forming oysters must be reared for two to three years before a pearl nucleus can be inserted into the adult oyster; 3) It generally takes another two to three years to produce gem quality pearls themselves; 4) A large work force is needed in pearl producing farms. Consequently, current methods of pearl production have inherent production limitations with resulting limited diversity in the world market and continued high price levels.
The present invention circumvents the use of live oysters for culturing pearls. It is a process based on a cell culture system specifically designed and developed to provide sustenance and nourishment to pearl forming tissues kept in vitro. The process involves sustaining the viability of mantle tissue explants by providing necessary chemical and physical 132196~
components in a culture medium. The composition of the medium to maintain and grow tissues includes a combination of nutrients associated with the naturally available medium in which the tissue grows. Accordingly, t:he present invention provides a method for coating a biocompatible nucleus with nacre in an in-vitro culture medium, said method comprising:
contacting a biocompatible nucleus with live mantle tissue of nacre producing members of the phylum mollusca in an appropriate nutrient medium;
said nutrient medium comprising salts simulating the natural medium of mantle tissue, a source of amino acids, a source of assimilable saccharide and at least one of mollusca blood, mollusca gonadal components, a source of steroid, yeast extract or fetal serum;
incubating said tissue under growth supporting conditions for sufficient time for said tissue to coat said nucleus with nacre; and isolating the resulting nacre coated nucleus.
In a further aspect, the present invention provides a nutrient medium for coating a biocompatible nucleus with nacre using mantle tissue said medium comprising:
a salt solution comprising salts simulating the natural medium associated with said mantle tissue;
a source of amino acids;
a source of assimilable saccharide;
at least one of mollusca blood, mollusca gonadal components, a source of steroid, yeast extract or fetal serum.
The mantle tis~ues found in all shell forming of the phylum Mollusca, including bivalves, and certain gastropods, undergo physiological metabolism to produce intercellular and later to secrete extracelluar matrix components responsible for the precipitation of nacreous (mother-of-pearl) material. In the present invention .
-` i32~ 96~
3a when mantle tissue is extracted from a mollusk and maintained under certain in vitro conditions, the tissue has physiological characteristics and functions duplicating those in normal biological conditions. The present invention uses complex growth media with the appropriate chemical and physical components necessary to simulate the ideal conditions in vitro for mantle tissues. By employing the media described in this invention the chemical and ultrastructural properties of the pearls produced by this invention are substantially identical to the naturally occurring or cultured pearls currently on the market, as has been demonstrated by a series of electron micrographs comparing the ultrastructure and chemical properties of conventionally cultured pearls with those of the pearls produced by the present invention. From transmission electron micrographs illustrating the surface structure of a conventionally produced cultured pearl presently found on the market and a pearl produced from the present invention, it could be seen that crystal size and shape of the nacre as well as general surface topography are substantially identical between the two pearls. Chemical identifications using X-ray diffraction of a conventionally produced cultured pearl and a pearl produced by the present invention showed that calcium carbonate (aragonite) is the predominate phase found in both pearls.
The culture media used in the process of this invention are complex growth media. The media employed may take many forms, normally providing an environment which to varying degrees approaches the natural fluids, cellular or extracelluar. For the most part, the medium will include inorganic salts, a source of amino acids, a source of metabolic energy, normally a metabolizable or assimilable saccharide source, and desirably a source of hormones. For the purposes of the sub~ect disclosure, the v`arious components of the sutrient medium which may be involved may be separated generally into the following components: (i) inorganic salts, (ii) amino acids, (iii) vitamins, (iv) naturally occurring protein containing compositions, (v) antibiotics and antimycotics, (vi) assimilable energy source and (vii) C2~ C3~ and/or 2-The nutrient medium will have the inorganicsalts necessary for growth of the tissue, approximating the natural medium. In addition, various other factors may be included, where some factors may be provided by the presence of other factors. In some instances, where naturally occurring materials are involved, the naturally occurring material may include the factors which are otherwise added to a synthetic medium. In other instances, the naturally occurring material may serve as an alternative to another component. Therefore, there may be wide variation in the media which are employed, and a number of different media may be employed, each with different degrees of success in the rapidity with which the pearls are obtained. For example, when using mollusk tissue as a component of the medium, the tissue ~,.
~, ' .
-"'; ' -1~2196~
may serve as a source of amino acids and hormones.Protein hydrolysates may serve as a source of amino acids, so that individual amino acids may not be :included. Conditioned medium from the growth of mantle tissue may be employed, where the conditioned medium may be replenished to previous levels of certain components such as an energy source and undesirable factors reduced to a desirable level.
The basic medium will have a salt medium approximating the natural medium of the tissue at an appropriate pH, a source of assimilable energy, a source of essential amino acids, and additional factors which promote growth. Such factors may include mollusca tissue, particularly the gonadal tissue components, which may also serve as the source of amino acids, fetal serum, a steroid source such as an androgen extract, yeast extract or the like.
The inorganic salts in the growth medium will usually contain all of the ions that are found in the mollusk mantle tissues themselves during their biological activities. In order to determine the chemical nature of the fluid surrounding the mantle tissue, the ionic concentrations of such fluid were investigated and determined. In Table I, the average concentrations of inorganic elements found are shown.
.~ .
.
6 1321~64 TABLE I
Inorqanic Elements Ion Concentration (a/1) Ca 0.387 Na 9.92 K 0.495 HCO3 0.223 Mg 1.233 C1 18.58 P 0.047 so4 2.69 As a result of the above results, compositions of inorganic salts were formulated for use in the complex growth medium as found in Table II below.
TABLE II
Inorqanic Salts Concentration (g/1) 20 Com~ound Limits Preferred NaC1 16.0 - 35.0 22.5 KCl 0.4 - 1.2 0.76 CaC12 0.8 - 1.4 1.08 MgC12-6H2O 0.7 - 14 10.3 Na2SO4 2.9 - 4.9 4.05 KHCO3 0.25 - 0.75 0.35 NaH2PO4-H2O 0.15 - 0.50 0.25 NaHCO3 0.1 - 0.2 0.12 The ~alt media proposed above are convenient, but other salt media may be formulated which would provide the desired ionic composition and normalities of the essential ions.
An amino acid analysis was also performed to identify and determine the concentrations of amino acids associated during pearl formation. Although ~r , ~
7 1 321~64 concentrations of the amino acids varies from mollusk to mollusk, the consistency of the amino acid concentrations for a given type of mollusk was noted. The average composition and concentration of amino acids found are shown in Table III below.
TABLE III
Amino Acids CompoundConcentration (residue/1000) 10 Alanine 221 Glycine 232 Aspartic Acid 132 Leucine 81.7 Arginine 71.7 15 Serine 57.8 Tyrosine 35.5 Phenylalanine 31.9 Glutamic Acid 33.5 Lysine 28.9 20 Valine 25~8 Proline 14.8 Isoleucine 14.5 Cysteine 11.5 Threonine 8.1 25 Methionine 6.2 Histidine 0.8 Cystine 0.2 -While the mollusk can produce most of the amino acids, in order to enhance growth, it is desirable to provide a supply of those amino acids which enhance the growth of the cells. As a result, certain amino acid components in similar concentrations may be used in the complex growth medium and are shown in Table IV below.
-- ~ .
i, 8 ~321964 TABLE IV
Amino Acids Concentration (g/1) 5 Compound Limits Preferred Glycine 0.75 - 5.5 4-5 L-alanine 2.5 - 4.6 2.8 L-arginine 0.8 - 2.5 2.4 L-asparagine 0.05 - 0.3 0.05 10 L-aspartic acid 0.32 - 0.95 0.6 L-cystine 0.1 - 0.15 0.1 L-glutamic acid 0.6 - 1.2 0.8 L-glutamine 0.1 - 1.0 0.25 L-histidine 0.50 - 2.8 2.1 15 L-isoleucine 0.01 - 0.075 0.05 L-leucine 0.01 - 0.1 0.05 L-lysine 0.2 - 0.4 0.2 L-methionine 0.01 - 0.75 0.05 L-phenylalanine 0.05 - 0.2 0.10 20 L-proline 0.1 - 1.5 0.25 L-serine 0.55 - 1.4 1.0 L-threonine 0.01 - 0.05 0.03 L-tryptophan 0.01 - 0.02 ~.01 L-tyrosine 0.05 - 0.15 0.1 25 L-valine 0.01 - 0.075 0.05 -Of particular interest as a source of individual amino acids are the amino acids serine, alanine, arginine, aspartic acid, glycine, histidine, leucine, methionine, and phenylalanine. In referring to amino acids, it is understood that the naturally occurring L-stereoisomer i8 intended. However, instead of individual amino acids, protein hydrolysates or extracts may be employed, by themselves or in conjunction with individual amino acids, where the protein hydrolysates or extracts may provide for a more economical source of amino acids.
. ~ . . ". :~
,, . , : :: ,i :. ,:;~ .
:. .;.... :. :. :
' ;: ' :.. ".- . :~: .::
, . ... . .
132196~
Vitamins are optional. If included, the vitamins present in the complex growth medium are similar to those used for other cell and tissue cultures with some variations in concentration. Specific vitamins and concentrations are shown in Table V below. None some or all may actually be used in the complex growth medium.
TABLE V
Vitamins Concentration (mg/l) Compound Limits Preferred Biotin 0.01 - 1 0.1 Riboflavin 0.01 - 1 0.01 I-Inositol 0.1 - 10 1.0 15 Thiamine 0.1 - 10 1.0 Niacin 0.1 - 10 1.0 Choline Chloride 0.1 - 10 1.0 Folic Acid 0.1 - 10 1.0 Ascorbic Acid 0.1 - 1 0.1 20 Vitamin A (acetate) 0.1 - 1 0.1 Pyridoxine 0.1 - 10 1.0 The hormones found associated at or near the activities of the mantle tissues were determined and may be classified as corticosteroids, androgens or modified versions of estrogen. These hormonal components or metabolic intermediates were added to the medium to facilitate biosynthesis of these hormones. Androgen extract may be obtained from commercial sources and may be used in amounts varying from 0.005 to 0.2 mg/L. It has been observed that a growth medium containing serum ~ extracts from the reproductive organs of the same mollusk ; was observed to yield the most success in proliferating the growth of the mantle tissues. The serum extracts were found to provide the levels of hormones necessary to sustain mantle tissue growth. Without the presence of this reproductive organ serum, however, the hormone additives, although not essential in maintaining tissue culture, were found to be desirable in enhancing tissue growth.
Of particular interest is to use tissue from the mantle explant source or other related species, particularly comprising gonadal tissue or lyophilized gonadal tissue. The tissue may be minced or ground either before or after lyophilization to provide the tissue in easily dispersible form~ e.g. a powder. The tissue when employed will be composed of cells, fragments of the cells and other materials present in the tissue when removed from the source. The lyophilized tissue may be dispersed in the nutrient medium under mild conditions with agitation, and may be incorporated in biocompatible gels, such as agar or collagen gels. The amount of the lyophilized tissue may be varied widely and may be optimized in accordance with the other components of the nutrient medium. Beneficial results may be obtained by using a ratio of from about 0.1 to 2 of the volume of the 2~ tissue prior to lyophilization to the volume of medium.
Antibiotics and antimycotics such as penicillin and streptomycin may also be used during tissue extraction procedures and may also be used to control contamination levels during mantle tissue culture. The antibiotics and antimycotics used in the complex growth medium are listed below in Table VI.
TABLE VI
Antibiotics and Antimycotics 30 Compound Concentration Streptomycin 50 - 200 yg/ml Penicillin G, Sodium 100 - 2,000 U/ml Although growth and maintenance of the mantle tissues were successful without the addition of a source of energy, at least one saccharide was added to the growth medium to provide an additional source of energy ~ , . ~
. , . ,, , :
, -;
,. .. , ~ : ~:
~-:. . . ~ ., .
: -,:, 1321~64 to the cells. Saccharide sources include glucose, galactose, glycogen, sucrose, etc.
Other components which were employed in one ox more formulated growth media are listed in Table VII
below. The lactalbumin hydrolysate provided significant benefits in the absence of other protein sources.
TABLE VII
Other Components Concentration Compound Limits Preferred Lactalbumin Hydrolysate 1.00 - 20.0 g/1 5.00 g/1 Mollusk/gastropod 1.00 - 100~ Volume 5% Volume own blood Fetal calf serum 0.01 - 10% Volume 0.05% Volume Yeast extract 1.0 - 20.0 g/1 10.00 g/1 Galactose 0.05 - 0.7 g/1 0.05 g/1 Glucose 1.00 - 5.0 g/1 2.00 g/1 Phenol red 5 mg/ml The system is buffeted to provide a physiologically acceptable pH. Sodium bicarbonate (inorganic salt) and phenol red were added to control and monitor the pH of the solution. The preferred pH range is 7.2 to 7.9. However, a pH as low as 6.5 and as high as 9.3 have been observed to sustain viability of the mantle tissues. Carbon dioxide enriched air or a carbonated source was added to the growth medium to keep the pH of the medium within the overall range of 6.6 to 8.9.
Commercially available cell culture media, e.g.
Gibco, Inc., New York, were modified and tested for culturing mantle tissues. The modifications made were generally: (i) addition of sodium bicarbonate and glucose, (ii) addition of appropriate concentrations of NaC1 to obtain the correct osmolality in the solutions, and (iii) 1 M NaOH solutions were often added to bring the pH in the solution to 7.4 or above.
.~
Various complex growth media compositions were used successfully in producing pearls. Specific examples are listed below in Tables VIIIA, VIIIB, AND VIIIC.
TABLE VIIIA
Complex Growth Medium "A"
Compound Concentration norganic Salts:
NaCl . 17.3 g/l 10 CaCl2 1.55 g/l KCl 0.85 g/l Mgcl2-6h2o 10.45 g/l NaHP04-H2O 0.20 g/1 NaHC03 0.12 g/1 Amino Acids:
Serine 10.5 g/1 Alanine 2.8 g/1 Aspartic Acid 0.6 g/1 Cystine 0.1 g/l 20 Glycine 7.5 g/l Glutamine 0.25 g/l Leucine 0.25 g/1 Other Components:
Galactose 0.7 mg/l 25 Glucose 1.0 mg/l Fetal Calf Serum (Gibco Lab., NY) 10~ Volume Niacin 1.0 mg/l Penicillin 100 U/ml Phenol Red 5.0 mg/ml , .. :
13 ~3219S4 TABLE VIIIB
Complex Growth Medium "B"
CompoundConcentration 5 Inorqanic Salts:
NaCl 22.8 g/l KC1 1.15 g/1 Na2HPO4-H20 g/l CaC12 1.5 g/1 10 NaHCO3 0.72 g/1 Amino Acids:
Serine 0.75 g/1 Alanine 2.8 g/1 Arginine 1.0 g/l 15 Aspartic Acid 0.5 g/1 Glycine 5.5 g/l Histidine 1.5 g/1 Leucine 0.1 g/1 Methionine 0.05 gll 20 Phenylalanine 0.03 g/1 Other Components:
Glucose 25 mg/1 Fetal Calf Serum 20% Volume Biofin 0.1 mg/1 25 Niacin 1.0 mg/1 Ascorbic Acid 0.1 mg/1 Vitamin A (acetate) 0.1 mg/1 Penicillin 100 U/ml Streptomycine 50 ~g/ml 30 Phenol Red 5 mg/ml _ TABLE VIIIC
Complex Growth Medium "C"
Compound Concentration Modified version of commercially available medium, i.e., Medium 199: Gibco Laboratories, Inc., Grand Island, NY.
Plus following additives:
;
_ .::.' ' ' . .. ..
' , ' . - ~
Yeast Extraction 10 g/l (Yeastolate: Gibco Lab) Penicillin 100 U/ml Phenol Red 5 mg/ml Formulations were prepared for growth media using distilled water containing the salt composition of Medium A or sea water and gonad organ extracts, where the gonad organ extracts were obtained by isolating the gonads from the body mass of the mollusc, lyophilizing the gonadal tissue and grinding the tissue to form a powder. The powder was then uniformly dispersed in the water by stirring. The amount of gonadal tissue was based on the original volume of the tissue and was in a volume ratio to water of 0.25 to 1. Other formulations combined the above formulation or used androgen extract (Sigma) in place of the gonadal tissue. The androgen extract ranged in the amount of 0.01 to 0.lmg/L.
,:
A portion or all of a mantle tissue is explanted from a mollusk or gastropod which belong to genus thereof which produce mother-of-pearl material in their shells, such as the genera Pinctada, Isognomon, ; Pteria, Pinna, Haliotis, Atrima, etc., e.g., Pinctada martensii, Pinctada margritifera, Pinctada maxima, Pinctada fucata, Pteria macroptera, Cristaria plicata, Tridacna gigas, Haliotis gigantea, Hypriopsis schlegeli, Haliotis fulgens, Haliotis corrugata, Haliotis cracherodii, Haliotis discus hannai, Ligumia nasuta, Elliptio complanata, Strophitus undulatus, Anodonta caturacta, and Lamsilis radiata, for the purpose of in -` vitro cultivation so as to produce nacreous material for pearl formation.
~ The pieces of the mantle tissue fragments are ; optionally washed in sea water containing antibiotics and/or antimycotics, e.g., 100 Units penicillin G (sodium ` ~
~, . .
. .
- : ~. :,. . . .
. , salt)/ml and 100 yg/ml streptomycin. The sea water may be prepared in the laboratory and would consist generally of water with inorganic salts in concentrations thereof as indicated in Table II above.
The tissue part(s) or intact mantle tissue(s) are transferred into a carbon dioxide or oxygen enriched complex growth medium comprised of inorganic salts, amino acids, vitamins and growth factors, hormones, antibiotics and antimycotics~ animal serum extracts and glucose.
Biocompatible material such as glass, porcelain, old shells containing calcite and/or the aragonite phase(s) of calcium carbonate, and/or calcium phosphates in the form of spheres or hemispheres are introduced into the medium for nacre deposition. The material which serves as a nucleating substrate may be of any shape, normally being round or ellipsoid for pearl formation. Usually, the smallest dimension of the material which serves as the substrate will be usually at least about lmm, usually at least about 2mm and may be a~
large as 20mm or larger. For pearls, the substrate will usually have a diameter from about 2 to 15, usually 7 to lOmm.
In one successful embodiment of the invention process, small, i.e., less than 1 mm3 pieces of mantle tissue were sectioned and removed from a pearl forming adult mollusk. Each piece was washed in salt water containing the inorganic salt components described above and placed in pre-sterilized culture dishes. Sterilized complex growth medium, filtered through a 0.22 ym millepore filter (Millepore Corp., Bedford, MA 01730) was immediately added to each dish containing the tissue fragments. Small nuclei, i.e., glass beads or ~pheres made from clam shells, were then placed in each dish and positioned so that maximal physical contact was made with the tissue. The cultures were maintained between 14C and 23C in the dark by incubation means. However, experimentation has shown that the invention process will , - . :
. .
:: :
. ~ .
:
withstand temperatures ranging from 8C to 29C. Carbon dioxide enriched air , ~
.
" 1321964 1~
was introduced and withdrawn in sufficient quantities to effectively keep the pH o the medium in a range from 6.6 to 8.9. The medium was replenished using syringes when the pH indicating phenol red changed color~. The bright p~henol red changes to a bluish red as the pH rise~ from 7.4 to 8. The bright phenol red changes shade toward pink or yellow as the pH drops from 7.4 to 6.5. The pH
of this medium tended, however, to ri~e. The removal of old medium and substitution of fresh medium took place every one to three days and continued until production of a pearl of desired quality and size was achieved.
Optionally, the medium is changed every two days or when the medium pH rises above 7.8, whichever occurs sooner and depending on tissue ma~s to medium content ratio.
Precise measurement of pH may be done with a pH measuring apparatus. After the pearl reached its desired quality and/or ~ize, it was removed from the dish and the attached tissue removed. The removed tissue was di~sected and fragments thereof used again in the production of additional pearls.
It is understood that the above described embodiment i~ merely illustrative of the application. Other embodiments, therefore, may be readily devised by those Ykilled in the art which will embody the principles of the invention and fall within the spirit and scope thereof. The appended claims are intended to cover such modifications and variations which are within the true scope and ~pirit of this invention.
Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity of underxtanding, it will be readily apparent to those of ordinary skill in the art in light of the teachings of this invention that certain changes and modifications may be made thereto witho~t departing from the spirit or ~cope of the appended claim~.
;~ , . ..
. .
.: :
' . ~ .
The subject invention concerns coating of nucleating agents with nacre in vitro using mantle tissue 5 from mollusca.
This invention relates to a methods and compositions of matter utilized therein, for culturing pearls, and in particular to a method of producing pearls by using an in vitro cell culture system to maintain biological and physiochemical activities of the mantle tissues found in pearl forming mollusks and gastropods.
A pearl is a gem most commonly formed by bivalve mollusks, particularly by several marine species known as pearl oysters. Pearls are formed as a protection against the irritation caused by foreign objects, generally parasites, grains of sand, or bits of gravel, which lodge inside the shell. A fold of soft tissue envelops the foreign particle and deposits layer after layer of nacre on it, similar to the mother-of-pearl lining the shell. Any shelled mollusk or gastropod is theoretically capable of producing a pearl, but most pearls exhibiting gem quality are produced by a specific genus of pinctada, haliotis, and certain freshwater bivalves.
Techniques for culturing pearls by using live pearl oysters were developed in Japan during the turn of the century. And today, these methods are still employed in which various saltwater and freshwater bivalves are maintained alive during the pearl forming stages.
30 Cultured pearls are generally produced by manuallyimplanting a nucleus with small pieces of mantle tissue in an oyster for approximately two to three years.
Over the years changes in the ecological environment, such as an increase in water pollution and 35 over harvesting of the pearl producing mollusks, have limited the potential productivity of the pearl . ~
.~
.
. ., . ~ .. :
': ' :: ' -: ' ' . ,, . : . ': ,, :
.
13219~
industries. Furthermore, existing methods of culturing pearls have inherent limitations: 1) Large areas of land and sea must be designated and utilized; 2) Pearl forming oysters must be reared for two to three years before a pearl nucleus can be inserted into the adult oyster; 3) It generally takes another two to three years to produce gem quality pearls themselves; 4) A large work force is needed in pearl producing farms. Consequently, current methods of pearl production have inherent production limitations with resulting limited diversity in the world market and continued high price levels.
The present invention circumvents the use of live oysters for culturing pearls. It is a process based on a cell culture system specifically designed and developed to provide sustenance and nourishment to pearl forming tissues kept in vitro. The process involves sustaining the viability of mantle tissue explants by providing necessary chemical and physical 132196~
components in a culture medium. The composition of the medium to maintain and grow tissues includes a combination of nutrients associated with the naturally available medium in which the tissue grows. Accordingly, t:he present invention provides a method for coating a biocompatible nucleus with nacre in an in-vitro culture medium, said method comprising:
contacting a biocompatible nucleus with live mantle tissue of nacre producing members of the phylum mollusca in an appropriate nutrient medium;
said nutrient medium comprising salts simulating the natural medium of mantle tissue, a source of amino acids, a source of assimilable saccharide and at least one of mollusca blood, mollusca gonadal components, a source of steroid, yeast extract or fetal serum;
incubating said tissue under growth supporting conditions for sufficient time for said tissue to coat said nucleus with nacre; and isolating the resulting nacre coated nucleus.
In a further aspect, the present invention provides a nutrient medium for coating a biocompatible nucleus with nacre using mantle tissue said medium comprising:
a salt solution comprising salts simulating the natural medium associated with said mantle tissue;
a source of amino acids;
a source of assimilable saccharide;
at least one of mollusca blood, mollusca gonadal components, a source of steroid, yeast extract or fetal serum.
The mantle tis~ues found in all shell forming of the phylum Mollusca, including bivalves, and certain gastropods, undergo physiological metabolism to produce intercellular and later to secrete extracelluar matrix components responsible for the precipitation of nacreous (mother-of-pearl) material. In the present invention .
-` i32~ 96~
3a when mantle tissue is extracted from a mollusk and maintained under certain in vitro conditions, the tissue has physiological characteristics and functions duplicating those in normal biological conditions. The present invention uses complex growth media with the appropriate chemical and physical components necessary to simulate the ideal conditions in vitro for mantle tissues. By employing the media described in this invention the chemical and ultrastructural properties of the pearls produced by this invention are substantially identical to the naturally occurring or cultured pearls currently on the market, as has been demonstrated by a series of electron micrographs comparing the ultrastructure and chemical properties of conventionally cultured pearls with those of the pearls produced by the present invention. From transmission electron micrographs illustrating the surface structure of a conventionally produced cultured pearl presently found on the market and a pearl produced from the present invention, it could be seen that crystal size and shape of the nacre as well as general surface topography are substantially identical between the two pearls. Chemical identifications using X-ray diffraction of a conventionally produced cultured pearl and a pearl produced by the present invention showed that calcium carbonate (aragonite) is the predominate phase found in both pearls.
The culture media used in the process of this invention are complex growth media. The media employed may take many forms, normally providing an environment which to varying degrees approaches the natural fluids, cellular or extracelluar. For the most part, the medium will include inorganic salts, a source of amino acids, a source of metabolic energy, normally a metabolizable or assimilable saccharide source, and desirably a source of hormones. For the purposes of the sub~ect disclosure, the v`arious components of the sutrient medium which may be involved may be separated generally into the following components: (i) inorganic salts, (ii) amino acids, (iii) vitamins, (iv) naturally occurring protein containing compositions, (v) antibiotics and antimycotics, (vi) assimilable energy source and (vii) C2~ C3~ and/or 2-The nutrient medium will have the inorganicsalts necessary for growth of the tissue, approximating the natural medium. In addition, various other factors may be included, where some factors may be provided by the presence of other factors. In some instances, where naturally occurring materials are involved, the naturally occurring material may include the factors which are otherwise added to a synthetic medium. In other instances, the naturally occurring material may serve as an alternative to another component. Therefore, there may be wide variation in the media which are employed, and a number of different media may be employed, each with different degrees of success in the rapidity with which the pearls are obtained. For example, when using mollusk tissue as a component of the medium, the tissue ~,.
~, ' .
-"'; ' -1~2196~
may serve as a source of amino acids and hormones.Protein hydrolysates may serve as a source of amino acids, so that individual amino acids may not be :included. Conditioned medium from the growth of mantle tissue may be employed, where the conditioned medium may be replenished to previous levels of certain components such as an energy source and undesirable factors reduced to a desirable level.
The basic medium will have a salt medium approximating the natural medium of the tissue at an appropriate pH, a source of assimilable energy, a source of essential amino acids, and additional factors which promote growth. Such factors may include mollusca tissue, particularly the gonadal tissue components, which may also serve as the source of amino acids, fetal serum, a steroid source such as an androgen extract, yeast extract or the like.
The inorganic salts in the growth medium will usually contain all of the ions that are found in the mollusk mantle tissues themselves during their biological activities. In order to determine the chemical nature of the fluid surrounding the mantle tissue, the ionic concentrations of such fluid were investigated and determined. In Table I, the average concentrations of inorganic elements found are shown.
.~ .
.
6 1321~64 TABLE I
Inorqanic Elements Ion Concentration (a/1) Ca 0.387 Na 9.92 K 0.495 HCO3 0.223 Mg 1.233 C1 18.58 P 0.047 so4 2.69 As a result of the above results, compositions of inorganic salts were formulated for use in the complex growth medium as found in Table II below.
TABLE II
Inorqanic Salts Concentration (g/1) 20 Com~ound Limits Preferred NaC1 16.0 - 35.0 22.5 KCl 0.4 - 1.2 0.76 CaC12 0.8 - 1.4 1.08 MgC12-6H2O 0.7 - 14 10.3 Na2SO4 2.9 - 4.9 4.05 KHCO3 0.25 - 0.75 0.35 NaH2PO4-H2O 0.15 - 0.50 0.25 NaHCO3 0.1 - 0.2 0.12 The ~alt media proposed above are convenient, but other salt media may be formulated which would provide the desired ionic composition and normalities of the essential ions.
An amino acid analysis was also performed to identify and determine the concentrations of amino acids associated during pearl formation. Although ~r , ~
7 1 321~64 concentrations of the amino acids varies from mollusk to mollusk, the consistency of the amino acid concentrations for a given type of mollusk was noted. The average composition and concentration of amino acids found are shown in Table III below.
TABLE III
Amino Acids CompoundConcentration (residue/1000) 10 Alanine 221 Glycine 232 Aspartic Acid 132 Leucine 81.7 Arginine 71.7 15 Serine 57.8 Tyrosine 35.5 Phenylalanine 31.9 Glutamic Acid 33.5 Lysine 28.9 20 Valine 25~8 Proline 14.8 Isoleucine 14.5 Cysteine 11.5 Threonine 8.1 25 Methionine 6.2 Histidine 0.8 Cystine 0.2 -While the mollusk can produce most of the amino acids, in order to enhance growth, it is desirable to provide a supply of those amino acids which enhance the growth of the cells. As a result, certain amino acid components in similar concentrations may be used in the complex growth medium and are shown in Table IV below.
-- ~ .
i, 8 ~321964 TABLE IV
Amino Acids Concentration (g/1) 5 Compound Limits Preferred Glycine 0.75 - 5.5 4-5 L-alanine 2.5 - 4.6 2.8 L-arginine 0.8 - 2.5 2.4 L-asparagine 0.05 - 0.3 0.05 10 L-aspartic acid 0.32 - 0.95 0.6 L-cystine 0.1 - 0.15 0.1 L-glutamic acid 0.6 - 1.2 0.8 L-glutamine 0.1 - 1.0 0.25 L-histidine 0.50 - 2.8 2.1 15 L-isoleucine 0.01 - 0.075 0.05 L-leucine 0.01 - 0.1 0.05 L-lysine 0.2 - 0.4 0.2 L-methionine 0.01 - 0.75 0.05 L-phenylalanine 0.05 - 0.2 0.10 20 L-proline 0.1 - 1.5 0.25 L-serine 0.55 - 1.4 1.0 L-threonine 0.01 - 0.05 0.03 L-tryptophan 0.01 - 0.02 ~.01 L-tyrosine 0.05 - 0.15 0.1 25 L-valine 0.01 - 0.075 0.05 -Of particular interest as a source of individual amino acids are the amino acids serine, alanine, arginine, aspartic acid, glycine, histidine, leucine, methionine, and phenylalanine. In referring to amino acids, it is understood that the naturally occurring L-stereoisomer i8 intended. However, instead of individual amino acids, protein hydrolysates or extracts may be employed, by themselves or in conjunction with individual amino acids, where the protein hydrolysates or extracts may provide for a more economical source of amino acids.
. ~ . . ". :~
,, . , : :: ,i :. ,:;~ .
:. .;.... :. :. :
' ;: ' :.. ".- . :~: .::
, . ... . .
132196~
Vitamins are optional. If included, the vitamins present in the complex growth medium are similar to those used for other cell and tissue cultures with some variations in concentration. Specific vitamins and concentrations are shown in Table V below. None some or all may actually be used in the complex growth medium.
TABLE V
Vitamins Concentration (mg/l) Compound Limits Preferred Biotin 0.01 - 1 0.1 Riboflavin 0.01 - 1 0.01 I-Inositol 0.1 - 10 1.0 15 Thiamine 0.1 - 10 1.0 Niacin 0.1 - 10 1.0 Choline Chloride 0.1 - 10 1.0 Folic Acid 0.1 - 10 1.0 Ascorbic Acid 0.1 - 1 0.1 20 Vitamin A (acetate) 0.1 - 1 0.1 Pyridoxine 0.1 - 10 1.0 The hormones found associated at or near the activities of the mantle tissues were determined and may be classified as corticosteroids, androgens or modified versions of estrogen. These hormonal components or metabolic intermediates were added to the medium to facilitate biosynthesis of these hormones. Androgen extract may be obtained from commercial sources and may be used in amounts varying from 0.005 to 0.2 mg/L. It has been observed that a growth medium containing serum ~ extracts from the reproductive organs of the same mollusk ; was observed to yield the most success in proliferating the growth of the mantle tissues. The serum extracts were found to provide the levels of hormones necessary to sustain mantle tissue growth. Without the presence of this reproductive organ serum, however, the hormone additives, although not essential in maintaining tissue culture, were found to be desirable in enhancing tissue growth.
Of particular interest is to use tissue from the mantle explant source or other related species, particularly comprising gonadal tissue or lyophilized gonadal tissue. The tissue may be minced or ground either before or after lyophilization to provide the tissue in easily dispersible form~ e.g. a powder. The tissue when employed will be composed of cells, fragments of the cells and other materials present in the tissue when removed from the source. The lyophilized tissue may be dispersed in the nutrient medium under mild conditions with agitation, and may be incorporated in biocompatible gels, such as agar or collagen gels. The amount of the lyophilized tissue may be varied widely and may be optimized in accordance with the other components of the nutrient medium. Beneficial results may be obtained by using a ratio of from about 0.1 to 2 of the volume of the 2~ tissue prior to lyophilization to the volume of medium.
Antibiotics and antimycotics such as penicillin and streptomycin may also be used during tissue extraction procedures and may also be used to control contamination levels during mantle tissue culture. The antibiotics and antimycotics used in the complex growth medium are listed below in Table VI.
TABLE VI
Antibiotics and Antimycotics 30 Compound Concentration Streptomycin 50 - 200 yg/ml Penicillin G, Sodium 100 - 2,000 U/ml Although growth and maintenance of the mantle tissues were successful without the addition of a source of energy, at least one saccharide was added to the growth medium to provide an additional source of energy ~ , . ~
. , . ,, , :
, -;
,. .. , ~ : ~:
~-:. . . ~ ., .
: -,:, 1321~64 to the cells. Saccharide sources include glucose, galactose, glycogen, sucrose, etc.
Other components which were employed in one ox more formulated growth media are listed in Table VII
below. The lactalbumin hydrolysate provided significant benefits in the absence of other protein sources.
TABLE VII
Other Components Concentration Compound Limits Preferred Lactalbumin Hydrolysate 1.00 - 20.0 g/1 5.00 g/1 Mollusk/gastropod 1.00 - 100~ Volume 5% Volume own blood Fetal calf serum 0.01 - 10% Volume 0.05% Volume Yeast extract 1.0 - 20.0 g/1 10.00 g/1 Galactose 0.05 - 0.7 g/1 0.05 g/1 Glucose 1.00 - 5.0 g/1 2.00 g/1 Phenol red 5 mg/ml The system is buffeted to provide a physiologically acceptable pH. Sodium bicarbonate (inorganic salt) and phenol red were added to control and monitor the pH of the solution. The preferred pH range is 7.2 to 7.9. However, a pH as low as 6.5 and as high as 9.3 have been observed to sustain viability of the mantle tissues. Carbon dioxide enriched air or a carbonated source was added to the growth medium to keep the pH of the medium within the overall range of 6.6 to 8.9.
Commercially available cell culture media, e.g.
Gibco, Inc., New York, were modified and tested for culturing mantle tissues. The modifications made were generally: (i) addition of sodium bicarbonate and glucose, (ii) addition of appropriate concentrations of NaC1 to obtain the correct osmolality in the solutions, and (iii) 1 M NaOH solutions were often added to bring the pH in the solution to 7.4 or above.
.~
Various complex growth media compositions were used successfully in producing pearls. Specific examples are listed below in Tables VIIIA, VIIIB, AND VIIIC.
TABLE VIIIA
Complex Growth Medium "A"
Compound Concentration norganic Salts:
NaCl . 17.3 g/l 10 CaCl2 1.55 g/l KCl 0.85 g/l Mgcl2-6h2o 10.45 g/l NaHP04-H2O 0.20 g/1 NaHC03 0.12 g/1 Amino Acids:
Serine 10.5 g/1 Alanine 2.8 g/1 Aspartic Acid 0.6 g/1 Cystine 0.1 g/l 20 Glycine 7.5 g/l Glutamine 0.25 g/l Leucine 0.25 g/1 Other Components:
Galactose 0.7 mg/l 25 Glucose 1.0 mg/l Fetal Calf Serum (Gibco Lab., NY) 10~ Volume Niacin 1.0 mg/l Penicillin 100 U/ml Phenol Red 5.0 mg/ml , .. :
13 ~3219S4 TABLE VIIIB
Complex Growth Medium "B"
CompoundConcentration 5 Inorqanic Salts:
NaCl 22.8 g/l KC1 1.15 g/1 Na2HPO4-H20 g/l CaC12 1.5 g/1 10 NaHCO3 0.72 g/1 Amino Acids:
Serine 0.75 g/1 Alanine 2.8 g/1 Arginine 1.0 g/l 15 Aspartic Acid 0.5 g/1 Glycine 5.5 g/l Histidine 1.5 g/1 Leucine 0.1 g/1 Methionine 0.05 gll 20 Phenylalanine 0.03 g/1 Other Components:
Glucose 25 mg/1 Fetal Calf Serum 20% Volume Biofin 0.1 mg/1 25 Niacin 1.0 mg/1 Ascorbic Acid 0.1 mg/1 Vitamin A (acetate) 0.1 mg/1 Penicillin 100 U/ml Streptomycine 50 ~g/ml 30 Phenol Red 5 mg/ml _ TABLE VIIIC
Complex Growth Medium "C"
Compound Concentration Modified version of commercially available medium, i.e., Medium 199: Gibco Laboratories, Inc., Grand Island, NY.
Plus following additives:
;
_ .::.' ' ' . .. ..
' , ' . - ~
Yeast Extraction 10 g/l (Yeastolate: Gibco Lab) Penicillin 100 U/ml Phenol Red 5 mg/ml Formulations were prepared for growth media using distilled water containing the salt composition of Medium A or sea water and gonad organ extracts, where the gonad organ extracts were obtained by isolating the gonads from the body mass of the mollusc, lyophilizing the gonadal tissue and grinding the tissue to form a powder. The powder was then uniformly dispersed in the water by stirring. The amount of gonadal tissue was based on the original volume of the tissue and was in a volume ratio to water of 0.25 to 1. Other formulations combined the above formulation or used androgen extract (Sigma) in place of the gonadal tissue. The androgen extract ranged in the amount of 0.01 to 0.lmg/L.
,:
A portion or all of a mantle tissue is explanted from a mollusk or gastropod which belong to genus thereof which produce mother-of-pearl material in their shells, such as the genera Pinctada, Isognomon, ; Pteria, Pinna, Haliotis, Atrima, etc., e.g., Pinctada martensii, Pinctada margritifera, Pinctada maxima, Pinctada fucata, Pteria macroptera, Cristaria plicata, Tridacna gigas, Haliotis gigantea, Hypriopsis schlegeli, Haliotis fulgens, Haliotis corrugata, Haliotis cracherodii, Haliotis discus hannai, Ligumia nasuta, Elliptio complanata, Strophitus undulatus, Anodonta caturacta, and Lamsilis radiata, for the purpose of in -` vitro cultivation so as to produce nacreous material for pearl formation.
~ The pieces of the mantle tissue fragments are ; optionally washed in sea water containing antibiotics and/or antimycotics, e.g., 100 Units penicillin G (sodium ` ~
~, . .
. .
- : ~. :,. . . .
. , salt)/ml and 100 yg/ml streptomycin. The sea water may be prepared in the laboratory and would consist generally of water with inorganic salts in concentrations thereof as indicated in Table II above.
The tissue part(s) or intact mantle tissue(s) are transferred into a carbon dioxide or oxygen enriched complex growth medium comprised of inorganic salts, amino acids, vitamins and growth factors, hormones, antibiotics and antimycotics~ animal serum extracts and glucose.
Biocompatible material such as glass, porcelain, old shells containing calcite and/or the aragonite phase(s) of calcium carbonate, and/or calcium phosphates in the form of spheres or hemispheres are introduced into the medium for nacre deposition. The material which serves as a nucleating substrate may be of any shape, normally being round or ellipsoid for pearl formation. Usually, the smallest dimension of the material which serves as the substrate will be usually at least about lmm, usually at least about 2mm and may be a~
large as 20mm or larger. For pearls, the substrate will usually have a diameter from about 2 to 15, usually 7 to lOmm.
In one successful embodiment of the invention process, small, i.e., less than 1 mm3 pieces of mantle tissue were sectioned and removed from a pearl forming adult mollusk. Each piece was washed in salt water containing the inorganic salt components described above and placed in pre-sterilized culture dishes. Sterilized complex growth medium, filtered through a 0.22 ym millepore filter (Millepore Corp., Bedford, MA 01730) was immediately added to each dish containing the tissue fragments. Small nuclei, i.e., glass beads or ~pheres made from clam shells, were then placed in each dish and positioned so that maximal physical contact was made with the tissue. The cultures were maintained between 14C and 23C in the dark by incubation means. However, experimentation has shown that the invention process will , - . :
. .
:: :
. ~ .
:
withstand temperatures ranging from 8C to 29C. Carbon dioxide enriched air , ~
.
" 1321964 1~
was introduced and withdrawn in sufficient quantities to effectively keep the pH o the medium in a range from 6.6 to 8.9. The medium was replenished using syringes when the pH indicating phenol red changed color~. The bright p~henol red changes to a bluish red as the pH rise~ from 7.4 to 8. The bright phenol red changes shade toward pink or yellow as the pH drops from 7.4 to 6.5. The pH
of this medium tended, however, to ri~e. The removal of old medium and substitution of fresh medium took place every one to three days and continued until production of a pearl of desired quality and size was achieved.
Optionally, the medium is changed every two days or when the medium pH rises above 7.8, whichever occurs sooner and depending on tissue ma~s to medium content ratio.
Precise measurement of pH may be done with a pH measuring apparatus. After the pearl reached its desired quality and/or ~ize, it was removed from the dish and the attached tissue removed. The removed tissue was di~sected and fragments thereof used again in the production of additional pearls.
It is understood that the above described embodiment i~ merely illustrative of the application. Other embodiments, therefore, may be readily devised by those Ykilled in the art which will embody the principles of the invention and fall within the spirit and scope thereof. The appended claims are intended to cover such modifications and variations which are within the true scope and ~pirit of this invention.
Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity of underxtanding, it will be readily apparent to those of ordinary skill in the art in light of the teachings of this invention that certain changes and modifications may be made thereto witho~t departing from the spirit or ~cope of the appended claim~.
;~ , . ..
. .
.: :
' . ~ .
Claims (8)
1. A method for coating a biocompatible nucleus with nacre in an in-vitro culture medium, said method comprising:
contacting a biocompatible nucleus with live mantle tissue of nacre producing members of the phylum mollusca in an appropriate nutrient medium;
said nutrient medium comprising salts simulating the natural medium of mantle tissue, a source of amino acids, a source of assimilable saccharide and at least one of mollusca blood, mollusca gonadal components, a source of steroid, yeast extract or fetal serum;
incubating said tissue under growth supporting conditions for sufficient time for said tissue to coat said nucleus with nacre; and isolating the resulting nacre coated nucleus.
contacting a biocompatible nucleus with live mantle tissue of nacre producing members of the phylum mollusca in an appropriate nutrient medium;
said nutrient medium comprising salts simulating the natural medium of mantle tissue, a source of amino acids, a source of assimilable saccharide and at least one of mollusca blood, mollusca gonadal components, a source of steroid, yeast extract or fetal serum;
incubating said tissue under growth supporting conditions for sufficient time for said tissue to coat said nucleus with nacre; and isolating the resulting nacre coated nucleus.
2. A method according to claim 1, wherein said nucleus is comprised of calcium carbonate.
3. A method according to any of claims 1, or 2 wherein said mollusca is Phinctada martensii, Pincatada margritifera, Pinctada maxima, Pinctada fucate, Pteria macroptera, Atrima japonica, Ostrea gigas, Unio margritifera, Cristaria plicata, Tridacna gigas, Haliotis gigantea, Hypriopsis schlegeli, Haliotis fulgens, Halictis corrugata, Haliotis cracherodii, Haliotis discus hannai, Ligumia nasuta, Elliptio complanata, Strophitus undulatus, Anodonta caturacta, or Lamsilis radiata.
4. A nacre coated nucleus produced according to the method of any of claims 1 or 2.
5. A nutrient medium for coating a biocompatible nucleus with nacre using mantle tissue said medium comprising:
a salt solution comprising salts simulating the natural medium associated with said mantle tissue;
a source of amino acids;
a source of assimilable saccharide;
at least one of mollusca blood, mollusca gonadal components, a source of steroid, yeast extract or fetal serum.
a salt solution comprising salts simulating the natural medium associated with said mantle tissue;
a source of amino acids;
a source of assimilable saccharide;
at least one of mollusca blood, mollusca gonadal components, a source of steroid, yeast extract or fetal serum.
6. A nutrient medium according to claim 5, wherein said source of amino acids includes at least one individual amino acid, said assimilable saccharide comprises at least one of glucose or galactose, and further comprises mollusca gonadal components.
7. A nutrient medium according to claim 5, wherein said source of amino acids includes at least one individual amino acid, said assimilable saccharide comprises at least one of glucose or galactose, and further comprises a source of steroid.
8. A composition comprising live mantle tissue incapable of developing into a mature mollusca from a nacre producing mollusca and, a biocompatible nucleus and a nutrient medium according to any of claims 5, 6 or 7.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10212787A | 1987-09-28 | 1987-09-28 | |
| US102,127 | 1987-09-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1321964C true CA1321964C (en) | 1993-09-07 |
Family
ID=22288251
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000578599A Expired - Fee Related CA1321964C (en) | 1987-09-28 | 1988-09-27 | Method for culturing pearls |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0335955A4 (en) |
| JP (1) | JPH02501441A (en) |
| KR (1) | KR890701006A (en) |
| AU (1) | AU611508B2 (en) |
| CA (1) | CA1321964C (en) |
| WO (1) | WO1989002919A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2682965A1 (en) * | 1991-10-23 | 1993-04-30 | Camprasse Georges | PRODUCTION OF BONE AND PEARL FROM CULTURE OF BONE FORMING CELLS. |
| FR2684686B1 (en) * | 1991-12-06 | 1994-12-23 | Bertin & Cie | CULTURE MEDIA FOR MARINE INVERTEBRATE CELLS. |
| US7062940B2 (en) | 2002-12-13 | 2006-06-20 | Chi Huynh | Carved pearl |
| JP2010509933A (en) * | 2006-11-22 | 2010-04-02 | インディアン カウンシル オブ アグリカルチュラル リサーチ | In-vitro pearl production method using marine organisms |
| CN110637763B (en) * | 2019-09-26 | 2021-05-04 | 中国科学院南海海洋研究所 | A kind of preparation method of Tridacna shell shape and mantle color characters interchangeable |
| CN110684709B (en) * | 2019-10-21 | 2021-01-22 | 福建罗屿岛食品有限公司 | A kind of disc abalone cell culture medium and construction method of cell line |
| CN112919943A (en) * | 2021-03-26 | 2021-06-08 | 生态环境部华南环境科学研究所 | Composting agent for efficiently removing steroid estrogen in livestock and poultry manure and aerobic composting method |
-
1988
- 1988-09-27 KR KR1019890700947A patent/KR890701006A/en not_active Withdrawn
- 1988-09-27 JP JP63508678A patent/JPH02501441A/en active Pending
- 1988-09-27 CA CA000578599A patent/CA1321964C/en not_active Expired - Fee Related
- 1988-09-27 EP EP19880909428 patent/EP0335955A4/en not_active Ceased
- 1988-09-27 AU AU26081/88A patent/AU611508B2/en not_active Ceased
- 1988-09-27 WO PCT/US1988/003325 patent/WO1989002919A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU611508B2 (en) | 1991-06-13 |
| JPH02501441A (en) | 1990-05-24 |
| WO1989002919A1 (en) | 1989-04-06 |
| AU2608188A (en) | 1989-04-18 |
| EP0335955A1 (en) | 1989-10-11 |
| KR890701006A (en) | 1989-12-19 |
| EP0335955A4 (en) | 1990-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Biesiot et al. | Changes in digestive enzyme activities during early development of the American lobster Homarus americanus Milne Edwards | |
| Ebner et al. | Cultivation and properties of bovine mammary cell cultures | |
| Rivkin et al. | Bacterivory: a novel feeding mode for asteroid larvae | |
| JP3839842B2 (en) | Tetraploid shellfish | |
| Desrosiers et al. | Early developmental events following fertilization in the giant scallop () Placopecten magellanicus | |
| EP0872180B1 (en) | Medium composition for external fertilization | |
| CN101491228B (en) | Sea no-nucleus pearl incubation method | |
| Cheng et al. | Aquaculture of the tropical sea cucumber, Stichopus monotuberculatus: Induced spawning, detailed records of gonadal and embryonic development, and improvements in larval breeding by digestive enzyme supply in diet | |
| Chen et al. | Establishment of cell lines derived from oyster, Crassostrea gigas Thunberg and hard clam, Meretrix lusoria Röding | |
| Higuchi | Cultivation of animal cells in chemically defined media, a review | |
| CA1321964C (en) | Method for culturing pearls | |
| Fraser et al. | Studies on primary cell cultures derived from ovarian tissue of Penaeus monodon | |
| Gong et al. | Characterization of calcium deposition and shell matrix protein secretion in primary mantle tissue culture from the marine pearl oyster Pinctada fucata | |
| Xing et al. | The potential value of different species of benthic diatoms as food for newly metamorphosed sea urchin Strongylocentrotus intermedius | |
| Wyss | Ecdysterone, insulin and fly extract needed for the proliferation of normal Drosophila cells in defined medium | |
| Mitsuhashi | Development of highly nutritive culture media | |
| Suja et al. | Effect of culture media and tissue extracts in the mantle explant culture of abalone, Haliotis varia Linnaeus | |
| US4449480A (en) | Culture of freshwater mussel glochidia in an artificial habitat utilizing complex liquid growth media | |
| CN118370247B (en) | Method for improving survival rate of hong Kong giant oyster under high-salt condition | |
| Le Marrec-Croq et al. | Primary cultures of heart cells from the scallp Pecten maximus (mollusca-bivalvia) | |
| CN108265021B (en) | Leech cell in-vitro culture medium and culture method thereof | |
| CN102429109A (en) | Methionine oligopeptide and application thereof in prawn feed | |
| Ferkovich et al. | Rearing of ectoparasitoid Diapetimorpha introita on an artificial diet: supplementation with insect cell line-derived factors | |
| Kirk et al. | Morphologically stable epithelial vesicles cultured from normal human endometrium in defined media | |
| Stanley | Cultivation of arthropod cells |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKLA | Lapsed |